학술논문
Clinical meaningfulness of a British Isles Lupus Assessment Group-based Composite Lupus Assessment response in terms of patient-reported outcomes in moderate to severe systemic lupus erythematosus: a post-hoc analysis of the phase 3 TULIP-1 and TULIP-2 trials of anifrolumab
Document Type
Article
Author
Source
In The Lancet Rheumatology March 2022 4(3):e198-e207
Subject
Language
ISSN
2665-9913